Literature DB >> 2224438

The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumours.

P F Mulders1, G O Oosterhof, C Boetes, P H de Mulder, A G Theeuwes, F M Debruyne.   

Abstract

Following chemotherapy for disseminated testicular cancer, 55 patients underwent surgery because of residual tumour. The histological findings were viable tumour in 12 patients, mature teratoma in 12 and fibrosis and/or necrosis in 31. Retroperitoneal abdominal masses were evaluated radiographically before and after chemotherapy. The reduction in size of these masses after chemotherapy appeared to have prognostic significance. A decrease of more than 70% was always associated with fibrosis. A residual mass over 50 mm indicated viable tumour or mature teratoma. Seminoma or embryonal carcinoma was more likely to result in fibrosis/necrosis in the resected tissue. Both the Indiana and the EORTC classification models can be used for prognosis. Radiographic measurements before and after chemotherapy are of considerable prognostic significance. These objective indicators help in planning treatment and so diminish the side effects of therapy and maintain or even increase the high cure rate in disseminated testicular cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2224438     DOI: 10.1111/j.1464-410x.1990.tb14967.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

Review 1.  Diagnosis and treatment of patients with testicular germ cell cancer.

Authors:  J T Hartmann; L Kanz; C Bokemeyer
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

2.  Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.

Authors:  E W Steyerberg; H J Keizer; J Zwartendijk; G L Van Rijk; C J Van Groeningen; J D Habbema; G Stoter
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

3.  Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer.

Authors:  E W Steyerberg; H J Keizer; S D Fosså; D T Sleijfer; D F Bajorin; J P Donohue; J D Habbema
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

4.  A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for non-seminoma germ cell tumours.

Authors:  Ciara Conduit; Wei Hong; Felicity Martin; Benjamin Thomas; Nathan Lawrentschuk; Jeremy Goad; Peter Grimison; Nariman Ahmadi; Ben Tran; Jeremy Lewin
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.